Akihiko Saito

This inventor holds 8 USPTO granted patents and 6 published patent applications, plus 3 CIPO patents and 9 EPO patents. Top assignees: Niigata University, Denka Seiken Co., Ltd., Denka Company Limited. Active years: 2011-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akihiko Saito. Retrieved from https://idiyas.com/inventor/akihiko-saito-5ruc8e3k

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 8 (Patent Applications = 6)

% Patents Active = 100.0

CIPO Patents = 3

EPO Patents = 9 (Patent Applications = 9)

Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 18(Granted Patents)

Company Filing History:

Denka Seiken Co., Ltd.

patents

2 out of 388

Denka Company Limited

Juntendo Education Foundation

patent

6. 1 out of 24

Juntendo Educational Foundation

patents

7. 1 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 2011-2025

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12239621 - Prevention of kidney injury induced by hemolytic reaction (2025-03-04),

2. 11304919 - Utilization of cilastatin in inhibiting renal disorder (2022-04-19),

3. 10420741 - Megalin antagonist (2019-09-24),

4. 8703430 - Method for measuring human megalin (2014-04-22),

5. 8663931 - Method for detecting renal disease comprising measuring human megalin in urine (2014-03-04),

6. 8628930 - Use of megalin in urine as marker for detecting renal disorder (2014-01-14),

7. 8105840 - Urine pretreatment agent for urinary protein quantitation, urine pretreatment method, and urinary protein quantitation method (2012-01-31),

8. 7955809 - Method for measuring human megalin (2011-06-07),

Title: Akihiko Saito: Innovator in Renal Injury Prevention

Introduction

Akihiko Saito is a notable inventor based in Niigata, Japan, recognized for his contributions to medical science, particularly in the field of renal injury prevention. With a total of eight patents to his name, Saito has made significant strides in developing innovative solutions to combat kidney injuries.

Latest Patents

Among his latest patents, Saito has focused on the prevention of kidney injury induced by hemolytic reactions. One of his inventions provides an inhibitor for renal injuries caused by such reactions, utilizing cilastatin or a pharmaceutically acceptable salt thereof. Additionally, he has developed a method for utilizing cilastatin to inhibit renal injuries induced by iodinated contrast mediums, further showcasing his commitment to advancing medical treatments.

Career Highlights

Saito has had a distinguished career, working with reputable institutions such as Niigata University and Denka Seiken Co., Ltd. His work has not only contributed to academic knowledge but has also had practical applications in the medical field, enhancing patient care and treatment options.

Collaborations

Throughout his career, Saito has collaborated with esteemed colleagues, including Shinya Ogasawara and Yoshiaki Hirayama. These partnerships have fostered a collaborative environment that has led to innovative breakthroughs in his research.

Conclusion

Akihiko Saito's work in renal injury prevention exemplifies the impact of innovation in medicine. His patents and collaborations reflect a dedication to improving health outcomes and advancing scientific knowledge.

Profile summary based on public USPTO records.